TY - JOUR T1 - Impact of COVID-19 mitigation measures on the incidence of preterm birth: a national quasi-experimental study JF - medRxiv DO - 10.1101/2020.08.01.20160077 SP - 2020.08.01.20160077 AU - Jasper V Been AU - Lizbeth Burgos Ochoa AU - Loes CM Bertens AU - Sam Schoenmakers AU - Eric AP Steegers AU - Irwin KM Reiss Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/08/04/2020.08.01.20160077.abstract N2 - Introduction Preterm birth is the leading cause of child mortality globally, with many survivors experiencing long-term adverse consequences. Preliminary evidence suggests that preterm births dropped dramatically following implementation of policy measures aimed at mitigating the impact of the COVID-19 pandemic.Methods We undertook a national quasi-experimental difference-in-regression-discontinuity approach to study the impact of the COVID-19 mitigation measures implemented in the Netherlands in a stepwise fashion on 9, 15, and 23 March 2020 on the incidence of preterm birth. We used data from the neonatal dried blood spot screening programme (2010−2020) and cross-validated these against national perinatal registry data. Stratified analyses were conducted according to gestational age subgroups, and sensitivity analyses to assess robustness of the findings. We explored potential effect modification by neighbourhood socio-economic status.Results Data on 1,599,547 singleton newborns were available, including 56,720 post-implementation births. Consistent reductions in preterm birth were seen across various time windows surrounding implementation of the 9 March COVID-19 mitigation measures: ±2 months (n=531,823): odds ratio 0.77 (95% confidence interval 0.66–0.91), p=0.002; ±3 months (n=796,531): 0.85 (0.73–0.98), p=0.028; ±4 months (n=1,066,872): 0.84 (0.73–0.97), p=0.023. Decreases observed following the 15 March measures were of smaller magnitude and not statistically significant. No changes were observed after 23 March. Preterm birth reductions after 9 March were consistent across gestational age strata and robust in sensitivity analyses. They appeared confined to high-socioeconomic status neighbourhoods, but effect modification was not statistically significant.Conclusion In this national quasi-experimental study, initial implementation of COVID-19 mitigation measures was associated with a 15-23% drop in preterm births in the following months, in agreement with preliminary observations in other countries. It is now of pivotal importance that integration of comparable data from across the globe is undertaken to further substantiate these findings and start exploring the underlying mechanisms.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNot applicableFunding StatementNo funding was received for this studyAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:According to Dutch law (WMO) no formal ethical review was required for this study. According to standard procedures and under strict conditions that were fulfilled, RIVM allows anonymised data registered as part of the screening programme to be used for research purposes with waiver of consent. A protocol for the study was develop a priori and approved by RIVM prior to data provision.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe authors are open to sharing data, however consent should be sought with the Dutch National Institute for Public Health and the Environment (RIVM) ER -